Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Letemendia, F. J. J.
Harris, A. D.
and
Willems, P. J. A.
1967.
The Clinical Effects on a Population of Chronic Schizophrenic Patients of Administrative Changes in Hospital.
British Journal of Psychiatry,
Vol. 113,
Issue. 502,
p.
959.
Letemendia, F. J. J.
and
Harris, A. D.
1967.
Chlorpromazine and the Untreated Chronic Schizophrenic: A Long-Term Trial.
British Journal of Psychiatry,
Vol. 113,
Issue. 502,
p.
950.
Jones, Ivor H.
1969.
Motor Behaviour of Chronic Schizophrenics.
British Journal of Psychiatry,
Vol. 115,
Issue. 524,
p.
843.
Jones, Ivor H.
Davies, J. M.
Buckle, R.
Hanna, W. H.
and
Pikler, N.
1970.
Comparison of Methylperidol and Trifluoperazine in the Treatment of Chronic, Underactive Schizophrenic Patients.
Australian & New Zealand Journal of Psychiatry,
Vol. 4,
Issue. 3,
p.
143.
Brackenridge, C. J.
and
Jones, I. H.
1971.
Relation of hypermagnesaemia to activity and neuroleptic drug therapy in schizophrenic states.
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 34,
Issue. 2,
p.
195.
Tanghe, A.
and
Th. M.Vereecken, J. L.
1972.
FLUSPIRILENE, AN INJECTABLE, AND PENFLURIDOL, AN ORAL LONG‐ACTING, NEUROLEPTIG.
Acta Psychiatrica Scandinavica,
Vol. 48,
Issue. 4,
p.
315.
Willems, P. J. A.
Letemendia, F. J. J.
and
Arroyave, F.
1973.
A Categorization for the Assessment of Prognosis and Outcome in the Treatment of Alcoholism.
British Journal of Psychiatry,
Vol. 122,
Issue. 571,
p.
649.
Beumont, P. J. V.
Corker, C. S.
Friesen, H. G.
Kolakowska, T.
Mandelbrote, B. M.
Marshall, J.
Murray, M. A. F.
and
Wiles, D. H.
1974.
The Effects of Phenothiazines on Endocrine Function: II.
British Journal of Psychiatry,
Vol. 124,
Issue. 582,
p.
420.
Kolakowska, T.
Wiles, D. H.
Gelder, M. G.
and
McNeilly, A. S.
1976.
Clinical significance of plasma chlorpromazine levels.
Psychopharmacology,
Vol. 49,
Issue. 1,
p.
101.
De Cuyper, H. J. A.
Van Praag, H. M.
and
Mulder, W. R. E. H.
1979.
Therapeutical significance of clopimozide in the treatment of chronic psychotic patients.
Acta Psychiatrica Scandinavica,
Vol. 59,
Issue. 5,
p.
561.
hall, John N.
1980.
Ward rating scales for long-stay patients: a review.
Psychological Medicine,
Vol. 10,
Issue. 2,
p.
277.
King, D. J.
Turkson, S. N. A.
Liddle, J.
and
Kinney, C. D.
1980.
Some Clinical and Metabolic Aspects of Propranolol in Chronic Schizophrenia.
British Journal of Psychiatry,
Vol. 137,
Issue. 5,
p.
458.
Liberakis, E. A.
1981.
Factors predisposing to institutionalism.
Acta Psychiatrica Scandinavica,
Vol. 63,
Issue. 4,
p.
356.
Myers, D. H.
Campbell, P. L.
Cocks, N. M.
Flowerdew, J. A.
and
Muir, A.
1981.
A Trial of Propranolol in Chronic Schizophrenia.
British Journal of Psychiatry,
Vol. 139,
Issue. 2,
p.
118.
Koralesky, Deanrta
Bryant, Sharon Bomheimer
Dull, Marcia
and
Kaufman, Maria J.
1982.
Evaluating the Long-Term Psychiatric Patient: The Progress Review Index.
Issues in Mental Health Nursing,
Vol. 4,
Issue. 4,
p.
287.
1989.
Adverse outcome of hip fractures in older schizophrenic patients.
American Journal of Psychiatry,
Vol. 146,
Issue. 3,
p.
377.
eLetters
No eLetters have been published for this article.